Is Sitagliptin Effective for Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients? A Double-blind Placebo-controlled Clinical Trial
Conclusions
Metabolic disturbances associated with olanzapine treatment in patients with schizophrenia can be modulated by sitagliptin.
Source: Journal of Clinical Psychopharmacology - Category: Psychiatry Tags: Brief Reports Source Type: research
More News: Cholesterol | Clinical Trials | Januvia | Laboratory Medicine | Psychiatry | Schizophrenia | Study | Sugar | Zyprexa